News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
During the October 29th RECOVER Research Review (R3) Seminar, researchers highlighted patterns in electronic health record (EHR) data in patients who developed Long COVID after a first, or subsequent COVID-19 reinfection. By reviewing patient medical records from as early as March 2020, the findings from these studies provide insights into potential risks associated with developing Long COVID.
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
Findings from this RECOVER study could inform future efforts to prevent Long COVID using repurposed prescription drugs.
Six new RECOVER research publications report findings from the initiative’s pathobiology, observational, and electronic health record (EHR) studies.
NIH-funded analysis of health record data shows severe reinfections often follow severe first infections.